M. Kanbak Et Al. , "Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects," ANAESTHESIA AND INTENSIVE CARE , vol.24, no.5, pp.559-563, 1996
Kanbak, M. Et Al. 1996. Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects. ANAESTHESIA AND INTENSIVE CARE , vol.24, no.5 , 559-563.
Kanbak, M., Kahraman, S., Celebioglu, B., Akpolat, N., Ercan, S., & Erdem, K., (1996). Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects. ANAESTHESIA AND INTENSIVE CARE , vol.24, no.5, 559-563.
Kanbak, M Et Al. "Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects," ANAESTHESIA AND INTENSIVE CARE , vol.24, no.5, 559-563, 1996
Kanbak, M Et Al. "Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects." ANAESTHESIA AND INTENSIVE CARE , vol.24, no.5, pp.559-563, 1996
Kanbak, M. Et Al. (1996) . "Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects." ANAESTHESIA AND INTENSIVE CARE , vol.24, no.5, pp.559-563.
@article{article, author={M Kanbak Et Al. }, title={Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects}, journal={ANAESTHESIA AND INTENSIVE CARE}, year=1996, pages={559-563} }